Replies to post #393985 on Amarin Corp Plc (AMRN)

[rosemountbomber]

I guess it is considered good that Amain’s scripts are holding steady, but the Generics are increasing their market share.

The other concern is when 2023 rolls around and brand V scripts get hit with the Federal BCBS and maybe other insurers dropping brand V coverage we won’t be hugging the 60K scripts anymore. How long before GV overtakes V?

Not to mention the colossal stupidity of docs writing scripts for Lovaza (for other than trig lowering). The dumbest educated bunch around.

Left Bonaire a couple of hours ago and heading home slowly.